Scott Maguire Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11000 S Oketo Ave, Worth, IL 60482 Phone: 708-671-5865 |
News Archive
Gilead Sciences, Inc. announced today that the European Commission has granted conditional marketing authorization for Cayston® 75 mg powder and solvent for nebuliser solution (aztreonam lysine) for the suppressive therapy of chronic pulmonary infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF) aged 18 years and older.
To prevent molecules migrating from plastic packaging into the food they contain, scientists are identifying each critical point where this phenomenon can occur, using a method inspired from aeronautics.
New research provides fascinating insight into mechanisms that underlie recovery after damage to a region of the brain important for memory and attention. The research, published by Cell Press in the November 4th issue of the journal Neuron, highlights the role of undamaged portions of the brain that can "take over" and support the recovery of function.
A US study has found that the most severe form of acute kidney injury has increased nationwide by an average 10% per year with the number of associated deaths doubling over the past decade.
› Verified 7 days ago